Vivek Roy

14.3k citations
258 papers · 11.4k · 4 hit papers · h-index 54

Impact in

  • Hematology top 0.1%
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Multiple Myeloma Research and Treatments 109
    • Hematopoietic Stem Cell Transplantation 24
    • Chronic Lymphocytic Leukemia Research 20

Vivek Roy

245 papers receiving 11.0k citations

Vivek Roy's Hit Papers

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy 2014 · 822 citations
8220+8+16Years since publication4008001.2k

Peers

Vivek Roy
Comparison fields: 5 of 95
  • Hematology 5.5k
  • Genetics 622
  • Pulmonary and Respiratory Medicine 1.1k
  • Oncology 687
  • Cancer Research 207
Replace Meir Wetzler with:
Meir Wetzler United States
Susan Michelle Geyer United States
Frank Griesinger Germany
Jacques‐Olivier Bay France
David P. Schenkein United States
Ravi Vij United States
J. Ford Switzerland
Jacob P. Laubach United States
Rami S. Komrokji United States
Donna Ellen Reece Canada
Vivek Roy relative to Meir Wetzler United States Meir Wetzler's profile →
Citations per field
00.5×2×4×5.8×
Meir Wetzler · 1×
Citations per year

Countries citing papers authored by Vivek Roy

Since Specialization
Citations

This map shows the geographic impact of Vivek Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Roy more than expected).

Fields of papers citing papers by Vivek Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Roy. The network helps show where Vivek Roy may publish in the future.

Co-authors

The 25 scholars most cited alongside Vivek Roy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vivek Roy Line = papers co-authored together Vivek Roy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 258 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer
Hit paper breakdown →
20011348
2
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Hit paper breakdown →
2014822
3
Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
Hit paper breakdown →
2009533
4
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
Hit paper breakdown →
2013413
5 2007298
6 2009265
7 2014230
8 2014222
9 2009212
10 2010190
11 2006186
12 2011184
13 2004180
14 2011166
15 2007164
16 2007163
17 2010163
18 2013140
19 2010137
20 2012133

About Vivek Roy

Vivek Roy is a scholar working on Hematology, Genetics, Oncology, Dermatology and Pathology and Forensic Medicine, having authored 258 papers that have together received 11.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (109 papers), Hematopoietic Stem Cell Transplantation (24 papers), Chronic Lymphocytic Leukemia Research (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers), CAR-T cell therapy research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Neutropenia and Cancer Infections (5 papers). The work is most often cited by research in Hematology (5.5k citations), Genetics (622 citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (687 citations) and Cancer Research (207 citations). Vivek Roy has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Robert Charles Flanigan, Nikhil C. Munshi, Shaji Kunnathu Kumar, Scott I. Bearman, J. R. Caton, Brent A. Blumenstein, E. David Crawford, Sydney E. Salmon, Patrick C. McGrath and Angela A. Dispenzieri. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Leukemia, Blood Cancer Journal and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact